Alto Neuroscience, Inc. (ANRO) Stock News & Chart | StockAdder

(ANRO)

Alto Neuroscience, Inc.

Stock chart and latest news for Alto Neuroscience, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Alto Neuroscience, Inc. News

PRO

Alto Neuroscience (NYSE: ANRO) registers 6M resale shares from private placement

Apr 10, 2026 Yahoo Finance

Alto Neuroscience, Inc. (NYSE:ANRO) is definitely on the radar of institutional investors who own 33% of the company

Dec 26, 2025 Stocktwits

ANRO Stock Falls After Hours On Failed Schizophrenia Study Results

Apr 1, 2026 Investing.com

Alto Neuroscience stock soars after FDA meeting clears path for depression drug

Oct 20, 2025 Sahm

Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Apr 3, 2026 Yahoo Finance

Here's Why Alto Neuroscience, Inc. (ANRO) is a Great Momentum Stock to Buy

Oct 23, 2025 Stock Titan

After a Phase 2 miss, Alto shifts focus to depression drug ALTO-207

Apr 1, 2026 Investing.com

Alto Neuroscience stock soars after FDA grants Fast Track designation

Oct 3, 2025 Yahoo Finance

Can Alto Neuroscience, Inc. (ANRO) Climb 27.45% to Reach the Level Wall Street Analysts Expect?

Oct 23, 2025 Stock Titan

Alto Neuroscience (NYSE: ANRO) shifts focus to ALTO-207 after ALTO-101 miss

Apr 1, 2026 Stock Titan

Biotech investors get two chances to meet Alto Neuroscience in March

Feb 23, 2026 Stock Titan

Neuropsychiatric biotech Alto joins Stifel 2026 virtual CNS forum